Pyridil carboxamides as 5HT2B/2C receptor antagonists
US5922733A · kind A · utility
97Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 1997 |
| Grant date | Jul 13, 1999 |
| Priority date | — |
| Expiry date | Jun 30, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E20/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel heterocyclic compounds having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of CNS disorders are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.